Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

Stopped Sponsor stopped development of the MedTone inhaler in favor of an improved device (Gen2 inhaler)

Conditions

• Diabetes, Type 1

Interventions

• DRUG: Technosphere Insulin
• DRUG: Insulin glargine
• DRUG: Insulin lispro

Sponsor

Mannkind Corporation